Your browser doesn't support javascript.
loading
Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury.
Hong, Ji Young; Shin, Mi Hwa; Douglas, Ivor S; Chung, Kyung Soo; Kim, Eun Young; Jung, Ji Ye; Kang, Young Ae; Kim, Se Kyu; Chang, Joon; Kim, Young Sam; Park, Moo Suk.
Afiliación
  • Hong JY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chuncheon Sacred Heart Hospital, Hallym University Medical Center, Chuncheon-si, Gangwon-do, 200-704, Republic of Korea.
  • Shin MH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Douglas IS; Division of Pulmonary Sciences and Critical Care Medicine, Denver Health Medical Center, University of Colorado School of Medicine, Denver, CO 80204, U.S.A.
  • Chung KS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Kim EY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Jung JY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Kang YA; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Kim SK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Chang J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Kim YS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea.
  • Park MS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Disease, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Republic of Korea pms70@yuhs.ac.
Clin Sci (Lond) ; 130(21): 1993-2003, 2016 11 01.
Article en En | MEDLINE | ID: mdl-27549114
Asunto(s)
Palabras clave
Buscar en Google
Imprimir
XML
PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lipopolisacáridos / Receptor EphA2 / Efrina-A1 / Lesión Pulmonar Tipo de estudio: Guideline Límite: Animals / Humans / Male Idioma: En Revista: Clin Sci (Lond) Año: 2016 Tipo del documento: Article
Buscar en Google
Imprimir
XML
PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lipopolisacáridos / Receptor EphA2 / Efrina-A1 / Lesión Pulmonar Tipo de estudio: Guideline Límite: Animals / Humans / Male Idioma: En Revista: Clin Sci (Lond) Año: 2016 Tipo del documento: Article